Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:26 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 1,391 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Pill Clear all

Conditions: Bipolar I Disorder, Bipolar II Disorder, Bipolar Disorder NOS
Interventions: Sensoril, Placebo; Drug · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Schizophrenia
Interventions: ABT-925, Placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 11
States / cities: Anaheim, California • Cerritos, California • Garden Grove, California + 7 more

Conditions: Transgender Women
Interventions: Placebo, Progesterone; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Postmenopausal Symptoms, Aging, Alzheimer Disease
Interventions: Cholinergic antagonist; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 50 Years to 70 Years · Female only
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: Nashville, Tennessee • Burlington, Vermont

Conditions: Migraine
Interventions: Treximet, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Menstrual Regulation, Menstrual Irregularity
Interventions: Misoprostol; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Female only
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Fresno, California

Conditions: Metrorrhagia
Interventions: Estradiol valerate/Dienogest (Natazia, Qlaira, BAY86-5027), Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 37
States / cities: Lake Havasu City, Arizona • Greenbrae, California • Los Angeles, California + 32 more

Conditions: Obesity
Interventions: Drisdol (Ergocalciferol) Vitamin D2, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 11 Years to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Aging, Metabolism
Interventions: Intermittent Fasting, 400 IU Vitamin E, 1000 mg Vitamin C; Other · Dietary Supplement
Lead sponsor: University of Florida; Other
Eligibility: 19 Years to 30 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Anxiety Disorders, Mood Disorders, Insomnia, Nightmares
Interventions: Behavioral Sleep Intervention, Prazosin, Placebo; Behavioral · Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 55 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Separation Anxiety Disorder
Interventions: Vilazodone, Placebo; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Hand Surgery, Wrist Surgery, Elbow Surgery, Fracture Fixation, Dupuytren Contracture, Finger Fracture, Wrist Arthropathy, Distal Radius Fracture
Interventions: Liposomal bupivacaine (LB), Dexamethasone; Drug
Lead sponsor: St. Luke's Hospital, Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Bethlehem, Pennsylvania

Conditions: Ecchymosis and Erythema Commonly Associated With Soft Tissue Filler Injections
Interventions: Multizyme Cellular Vitality Cyruta Plus SHEP; Dietary Supplement
Lead sponsor: DeNova Research; Other
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: PTSD, Alcohol Abuse, Alcoholism
Interventions: Topiramate, Placebo administration; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pediatric Crohn's Disease
Interventions: Methotrexate, Sugar pill (placebo); Drug · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Up to 20 Years
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 32
States / cities: Birmingham, Alabama • Alto, California • New Haven, Connecticut + 27 more

Conditions: Medication Adherence
Interventions: ID Capsule, Riboflavin, Prompts; Other · Dietary Supplement · Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Obesity
Interventions: Behavioral Treatment, Placebo, Phentermine 15 MG; Behavioral · Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 70 Years
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections
Interventions: Emtricitabine (FTC), Tenofovir Disoproxil Fumarate (TDF), Efavirenz (EFV), FTC/TDF, FTC/TDF/EFV, Lamivudine/zidovudine; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 517 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 5
States / cities: Beverly Hills, California • Washington D.C., District of Columbia • Orlando, Florida + 2 more

Conditions: Metabolic Syndrome X
Interventions: TA-65; Dietary Supplement
Lead sponsor: University of Connecticut; Other
Eligibility: 32 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Knee Osteoarthritis
Interventions: Blinded study medication; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 45 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: bevacizumab, Erlotinib; Drug
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 70 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 7
States / cities: Galloway, New Jersey • Mount Holly, New Jersey • Paoli, Pennsylvania + 2 more

Conditions: Postmenopausal Syndrome
Interventions: Estrogen, Progesterone, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 55 Years to 75 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Smoking Cessation, Opioid Related Disorders
Interventions: varenicline; Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Autism Spectrum Disorders
Interventions: Placebo, Mirtazapine; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 5 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 2
States / cities: Indianapolis, Indiana • Lexington, Massachusetts

Search by objective public record fields.

Sensoril(Ashwaganhda)for Bipolar Disorder

An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

Progesterone in Gender Affirming Hormone Therapy Study

Cholinergic Health After Menopause (CHAMP)

Ictal and Interictal Inflammatory Markers in Migraine

Missed Period Pill Study

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Effect of Vitamin D Supplementation on Inflammation and Cardiometabolic Risk Factors in Obese Adolescents

Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress

Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)

Vilazodone for Separation Anxiety Disorder

The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery

A Study of Nutritional Supplementation in Altering Ecchymosis, Erythema and Health Outcomes Associated With Aesthetic Procedures

Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy

Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Smart Capsule for Automatic Adherence Monitoring

Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

Effects of TA-65, a Telomerase Activator on Metabolic Syndrome

Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis

Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer

Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism

Smoking Cessation & Opioid Dependence Treatment Integration

Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders